Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rxo (RXO) Debt to Equity (2022 - 2025)

Rxo (RXO) has disclosed Debt to Equity for 4 consecutive years, with $0.26 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity rose 14.84% year-over-year to $0.26, compared with a TTM value of $0.26 through Dec 2025, up 14.84%, and an annual FY2025 reading of $0.26, up 14.84% over the prior year.
  • Debt to Equity was $0.26 for Q4 2025 at Rxo, up from $0.26 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.78 in Q1 2023 and bottomed at $0.01 in Q3 2022.
  • Average Debt to Equity over 4 years is $0.46, with a median of $0.43 recorded in 2023.
  • The sharpest move saw Debt to Equity surged 7902.71% in 2023, then crashed 71.13% in 2024.
  • Year by year, Debt to Equity stood at $0.78 in 2022, then dropped by 22.03% to $0.6 in 2023, then plummeted by 62.23% to $0.23 in 2024, then increased by 14.84% to $0.26 in 2025.
  • Business Quant data shows Debt to Equity for RXO at $0.26 in Q4 2025, $0.26 in Q3 2025, and $0.25 in Q2 2025.